Wu L - Search Results

1

Multi-omics data identified TP53 and LRP1B as key regulatory gene related to immune phenotypes via EPCAM in HCC.

Shi L, Cao J, Lei X, Shi Y, Wu L. Shi L, et al. Among authors: wu l. Cancer Med. 2022 May;11(10):2145-2158. doi: 10.1002/cam4.4594. Epub 2022 Feb 12. Cancer Med. 2022. PMID: 35150083 Free PMC article.

2

Serum peroxiredoxin3 is a useful biomarker for early diagnosis and assessemnt of prognosis of hepatocellular carcinoma in Chinese patients.

Shi L, Wu LL, Yang JR, Chen XF, Zhang Y, Chen ZQ, Liu CL, Chi SY, Zheng JY, Huang HX, Yu FJ, Lin XY. Shi L, et al. Among authors: wu ll. Asian Pac J Cancer Prev. 2014;15(7):2979-86. doi: 10.7314/apjcp.2014.15.7.2979. Asian Pac J Cancer Prev. 2014. PMID: 24815434 Free article.

3

miR-340 reverses cisplatin resistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway.

Shi L, Chen ZG, Wu LL, Zheng JJ, Yang JR, Chen XF, Chen ZQ, Liu CL, Chi SY, Zheng JY, Huang HX, Lin XY, Zheng F. Shi L, et al. Among authors: wu ll. Asian Pac J Cancer Prev. 2014;15(23):10439-44. doi: 10.7314/apjcp.2014.15.23.10439. Asian Pac J Cancer Prev. 2014. PMID: 25556489 Free article.

4

MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.

Shi L, Wu L, Chen Z, Yang J, Chen X, Yu F, Zheng F, Lin X. Shi L, et al. Among authors: wu l. Cell Physiol Biochem. 2015;35(6):2333-48. doi: 10.1159/000374036. Epub 2015 Apr 15. Cell Physiol Biochem. 2015. PMID: 25896253 Free article.

5

Evaluation of miR-182/miR-100 Ratio for Diagnosis and Survival Prediction in Bladder Cancer.

Chen Z, Wu L, Lin Q, Shi J, Lin X, Shi L. Chen Z, et al. Among authors: wu l. Arch Iran Med. 2016 Sep;19(9):645-51. Arch Iran Med. 2016. PMID: 27631180

6

NRAL mediates cisplatin resistance in hepatocellular carcinoma via miR-340-5p/Nrf2 axis.

Wu LL, Cai WP, Lei X, Shi KQ, Lin XY, Shi L. Wu LL, et al. J Cell Commun Signal. 2019 Mar;13(1):99-112. doi: 10.1007/s12079-018-0479-x. Epub 2018 Jul 20. J Cell Commun Signal. 2019. PMID: 30030687 Free PMC article.

7

lncRNA KRAL reverses 5-fluorouracil resistance in hepatocellular carcinoma cells by acting as a ceRNA against miR-141.

Wu L, Pan C, Wei X, Shi Y, Zheng J, Lin X, Shi L. Wu L, et al. Cell Commun Signal. 2018 Aug 17;16(1):47. doi: 10.1186/s12964-018-0260-z. Cell Commun Signal. 2018. PMID: 30119680 Free PMC article.

8

TiRNA-Gly-GCC-002 is associated with progression in patients with hepatocellular carcinoma.

Wu L, Zhang L, Cao J, Sun Y, Zhang J, Shi L, Xia Y. Wu L, et al. Transl Cancer Res. 2024 Sep 30;13(9):4775-4785. doi: 10.21037/tcr-24-644. Epub 2024 Sep 27. Transl Cancer Res. 2024. PMID: 39430835 Free PMC article.

9

Expression of β-tubulin III and survivin in advance stage breast cancer correlates with chemotherapeutic effects of docetaxel.

Yuan SF, Zhu LJ, Zheng WE, Chen H, Wu LL, Zhang W, Sun HY, Chen WJ. Yuan SF, et al. Asian Pac J Cancer Prev. 2012;13(1):361-5. doi: 10.7314/apjcp.2012.13.1.361. Asian Pac J Cancer Prev. 2012. PMID: 22502701 Free article.

10

miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.

Lin QY, Wang JQ, Wu LL, Zheng WE, Chen PR. Lin QY, et al. Breast Cancer. 2020 Jan;27(1):147-158. doi: 10.1007/s12282-019-01002-0. Epub 2019 Aug 13. Breast Cancer. 2020. PMID: 31410735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33,235 results

Search Page

Filters